Fulcrum Therapeutics, Inc.
2021 Q4 - 2026 Q1 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q1 | 5/15/2026 | 9 | 0.0% | 1,182 | 3/31/2026 |
| 2024 Q4 | 2/7/2025 | 0 | 0.0% | 3 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 9 | 0.0% | 2,475 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 15 | 0.0% | 2,475 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 23 | 0.0% | 2,482 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 14 | 0.0% | 2,023 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 9 | 0.0% | 2,023 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 9 | 0.0% | 2,691 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 30 | 0.0% | 10,449 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 19 | 0.0% | 2,655 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 21 | 0.0% | 2,655 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 13 | 0.0% | 2,655 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 63 | 0.0% | 2,655 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 47 | 0.0% | 2,655 | 12/31/2021 |